BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24212890)

  • 21. Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation.
    Woodrow JP; Shlobin OA; Barnett SD; Burton N; Nathan SD
    J Heart Lung Transplant; 2010 Oct; 29(10):1159-64. PubMed ID: 20580267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchiolitis obliterans syndrome in lung transplant recipients: correlation of computed tomography findings with bronchiolitis obliterans syndrome stage.
    Choi YW; Rossi SE; Palmer SM; DeLong D; Erasmus JJ; McAdams HP
    J Thorac Imaging; 2003 Apr; 18(2):72-9. PubMed ID: 12700480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.
    Davis RD; Lau CL; Eubanks S; Messier RH; Hadjiliadis D; Steele MP; Palmer SM
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):533-42. PubMed ID: 12658195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients.
    Hohlfeld J; Niedermeyer J; Hamm H; Schäfers HJ; Wagner TO; Fabel H
    J Heart Lung Transplant; 1996 Sep; 15(9):888-94. PubMed ID: 8889984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
    Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
    Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obliterative bronchiolitis in lung allografts removed at retransplant for intractable airway problems.
    Akindipe O; Fernandez-Bussy S; Jantz M; Lu L; Deem A; Swafford W; Staples E; Baz M
    Respirology; 2009 May; 14(4):601-5. PubMed ID: 19383111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.
    Cooper JD; Billingham M; Egan T; Hertz MI; Higenbottam T; Lynch J; Mauer J; Paradis I; Patterson GA; Smith C
    J Heart Lung Transplant; 1993; 12(5):713-6. PubMed ID: 8241207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome.
    Langenbach SY; Zheng L; McWilliams T; Levvey B; Orsida B; Bailey M; Williams TJ; Snell GI
    J Heart Lung Transplant; 2005 Oct; 24(10):1550-6. PubMed ID: 16210129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in induced sputum in the presence of bronchiolitis obliterans syndrome and correlation with spirometry in single and bilateral lung transplant recipients.
    Allen DJ; Fildes JE; Yonan N; Leonard CT
    J Heart Lung Transplant; 2005 Jan; 24(1):88-91. PubMed ID: 15653385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathologic correlates of bronchiolitis obliterans syndrome in pulmonary retransplant recipients.
    Martinu T; Howell DN; Davis RD; Steele MP; Palmer SM
    Chest; 2006 Apr; 129(4):1016-23. PubMed ID: 16608952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple breath washout in pediatric patients after lung transplantation.
    Nyilas S; Carlens J; Price T; Singer F; Müller C; Hansen G; Warnecke G; Latzin P; Schwerk N
    Am J Transplant; 2018 Jan; 18(1):145-153. PubMed ID: 28719135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
    Morrell MR; Despotis GJ; Lublin DM; Patterson GA; Trulock EP; Hachem RR
    J Heart Lung Transplant; 2010 Apr; 29(4):424-31. PubMed ID: 19853479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.
    Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J
    J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation.
    Walter JN; Fan LL; Bag R; Zhang H; Doan M; Mallory GB; Elidemir O
    Transplantation; 2006 Sep; 82(5):709-11. PubMed ID: 16969297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive investigations for the early detection of chronic airways dysfunction following lung transplantation.
    Cook RC; Fradet G; Müller NL; Worsely DF; Ostrow D; Levy RD
    Can Respir J; 2003 Mar; 10(2):76-83. PubMed ID: 12687027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome.
    Burton CM; Carlsen J; Mortensen J; Andersen CB; Milman N; Iversen M
    J Heart Lung Transplant; 2007 Jul; 26(7):681-6. PubMed ID: 17613397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation.
    Reams BD; Musselwhite LW; Zaas DW; Steele MP; Garantziotis S; Eu PC; Snyder LD; Curl J; Lin SS; Davis RD; Palmer SM
    Am J Transplant; 2007 Dec; 7(12):2802-8. PubMed ID: 17924993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
    Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
    Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.